Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;27(46):2200846.
doi: 10.2807/1560-7917.ES.2022.27.46.2200846.

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021

Anke Kohlenberg  1 , Dominique L Monnet  1 , Diamantis Plachouras  1 ; Candida auris survey collaborative group  2 ; Candida auris survey collaborative group includes the following national experts
Collaborators, Affiliations

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021

Anke Kohlenberg et al. Euro Surveill. 2022 Nov.

Abstract

The number of cases of Candida auris infection or carriage and of countries reporting cases and outbreaks increased in the European Union and European Economic Area during 2020 and 2021. Eight countries reported 335 such cases in 2020 and 13 countries 655 cases in 2021. Five countries experienced outbreaks while one country reported regional endemicity. These findings highlight the need for adequate laboratory capacity and surveillance for early detection of C. auris and rapid implementation of control measures.

Keywords: Candida; Europe; fungal infections; healthcare-associated infections; multidrug-resistance; outbreak; surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: K. L. received consultancy fees from MRM Health, MSD and Gilead, speaker fees from FUJIFILM WAKO, Pfizer and Gilead and a service fee from Thermo fisher Scientific and TECOmedical.

M.C.A. has, over the past 5 years, received research grants/contract work (paid to the SSI) from Amplyx, Basilea, Cidara, F2G, Gilead, Novabiotics and Scynexis, and speaker honoraria (personal fee) from Astellas, Chiesi, Gilead, MSD, and SEGES. She is the current chairman of the EUCAST-AFST.

P.E.V. received research grants from F2G and Gilead Sciences (institution contracted for research grants), honoraria for lectures from F2G, Gilead Sciences and Pfizer (paid to institution) and has participated on advisory boards for F2G and Mundipharma (payment to institution) in the past 36 months.

J. A. P. has, in the last five years, given talks and consulted for MSD, Pfizer, Gilead, Astra-Zeneca, AOP Orphan Pharmaceuticals, Cepheid, Jansen.

A. A. I. has, over the past 5 years, received honoraria for educational talks on behalf of Gilead and Pfizer.

Figures

Figure 1
Figure 1
Reported cases of Candida auris infection or carriage, EU/EEA, 2013–2021 (n = 1,812)a
Figure 2
Figure 2
Epidemiological stage of Candida auris spreada, assessment by survey respondents in EU/EEA countries, 2022 (n = 30 countries)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D, Candida auris survey collaborative group . Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017. Euro Surveill. 2018;23(13). 10.2807/1560-7917.ES.2018.23.13.18-00136 - DOI - PMC - PubMed
    1. Plachouras D, Lötsch F, Kohlenberg A, Monnet DL, Candida auris survey collaborative group . Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019. Euro Surveill. 2020;25(12). 10.2807/1560-7917.ES.2020.25.12.2000240 - DOI - PMC - PubMed
    1. European Centre for Disease Prevention and Control (ECDC). Candida auris outbreak in healthcare facilities in northern Italy, 2019-2021. Rapid risk assessment. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-ca...
    1. Lötsch F, Albiger B, Monnet DL, Struelens MJ, Seifert H, Kohlenberg A, et al. Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Euro Surveill. 2020;25(45). 10.2807/1560-7917.ES.2020.25.45.2001735 - DOI - PMC - PubMed
    1. Brolund A, Lagerqvist N, Byfors S, Struelens MJ, Monnet DL, Albiger B, et al. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018. Euro Surveill. 2019;24(9). 10.2807/1560-7917.ES.2019.24.9.1900123 - DOI - PMC - PubMed

LinkOut - more resources